Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
BPA Chemical in Plastic Linked to Problems for Monkeys September 5, 2008 AboutLawsuits Add Your Comments According to a study published in the Proceeding of the National Academy of Sciences, researchers from the Yale School of Medicine have indicated that the Bisphenol A, or BPA, chemical found in a variety of hard plastic products can alter brain function and bring about mood disorders in monkeys. The study was released one day after the U.S. government released a report expressing that the plastic bottle chemicals raise some concerns for humans. BPA, a compound that provides an unbreakable quality to polycarbonate plastic products, was approved for commercial use in the 1950s. The chemical is used in the manufacture of several products, such as baby bottles, sports bottles, compact discs and food containers. Various animal studies over the last 10 years have raised concerns about the potential health effects BPA could have on humans, and particularly children. According to a recent federal study, the chemical is found in the urine of about 93 percent of the population. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The Yale study is the first time the commonly used chemical has been connected to health problems in primates. Researchers exposed the monkeys to bisphenol A levels that were considered safe for humans by the EPA (Environmental Protection Agency), and found that the compound intervened with brain cell connections crucial for learning, memory and mood. The findings suggest that minimum BPA exposure could extensively affect the structure and function of the brain. Csaba Leranth, professor of obstetrics, gynecology and reproductive sciences, and neurobiology at the Yale School of Medicine, said, “Our goal was to more closely mimic the slow and continuous conditions under which humans would normally be exposed to BPA.” Yesterday we reported on a final report released this week by the National Toxicology Program (NTP) of the U.S. Department of Health and Human Services. Although the FDA has previously issued statements supporting the safety of BPA use, the NTP report indicated that there remains considerable uncertainty about whether the plastic bottle chemical could impair human development. The National Toxicology Program, which is a part of the National Institutes of Health, is not vested with the authority to regulate BPA, but other federal agencies, including the Food and Drug Administration and the EPA, which are in charge of setting exposure limits for compounds, make use of its findings. The FDA is holding an advisory panel meeting of independent experts on September 16, 2008 to discuss the issue further. It is unclear whether the NTP report and this new research from Yale School of Medicine may cause the FDA to take a new position on the safety of the use of the BPA chemical, especially in baby bottles and other infant products. If a decision is reached to ban BPA, as regulators have indicated they intend to do in Canada, it would likely affect thousands of manufacturers who generate billions of dollars in profit off of the chemical. It would also likely renew interest in BPA chemical lawsuits for individuals who have suffered health risks that can be tied to the plastic bottle chemical. Tags: Baby Bottle, Bisphenol A, BPA, Plastic Image Credit: | More Lawsuit Stories New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement April 3, 2025 Food Manufacturers Seek Dismissal of Ultra-Processed Food Childhood Diabetes Lawsuit April 3, 2025 Flavored Vape Restrictions Upheld by Supreme Court April 3, 2025 1 Comments George Bittner, Ph.D. September 9, 2008 Legislators, consumers, and regulatory agencies should have well-justified concerns about the estrogenic activity (EA) exhibited by BPA and phthalates in water bottles and other plastics like baby bottles. While estrogens occur naturally in the body, many scientific studies have shown that significant health problems can occur when chemicals are ingested that mimic or block the actions of these female sex hormones; the fetus, newborn, or young child is especially vulnerable. However, BPA and phthalates are just two of several hundred chemicals that exhibit EA in plastics. These chemicals having EA leach from almost all plastics sold today, including polyethylene, polypropylene, PET, etc. That is, plastics advertised as BPA-free or phthalate-free are not EA-free; almost all these plastics still leach chemicals having EA – and often have more total EA than plastics that release BPA or phthalates. Current legislation is attempting to solve this problem by removing chemicals having EA (BPA, phthalates) one at a time. This approach, for legislators or the FDA, is not an appropriate solution for consumers because thousands of chemicals used in plastics exhibit EA, not just BPA and phthalates. This approach is a marketing-driven solution, not a health-driven solution. The appropriate health-driven solution is to manufacture safer plastics that are EA-free. This is not a pie-in-the-sky solution, as the technology already exists to produce EA-free plastics that also have the same advantageous physical properties, as do almost all existing EA-releasing plastics on the market today. In fact, some of these advanced-technology EA-free plastics are already in the marketplace. The cost of these safer EA-free plastics are just pennies more than EA-releasing plastics, when both are used to manufacture the same product in similar quantities. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (Posted: today) In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery. MORE ABOUT: HERNIA MESH LAWSUITHernia Surgery Malpractice Lawsuit Cleared To Move Forward Over Botched Procedure (03/21/2025)Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (03/14/2025)Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025) Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: yesterday) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 2 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (Posted: today) In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery. MORE ABOUT: HERNIA MESH LAWSUITHernia Surgery Malpractice Lawsuit Cleared To Move Forward Over Botched Procedure (03/21/2025)Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (03/14/2025)Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: yesterday) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 2 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)